- Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
Clinical trials
-
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma -
Hypothyroidism: Efficacy and Safety of Armour Thyroid Treatment in Subjects with Primary Hypothyroidism - Investigators
- Joe M Chehade, Christian A Koch, Payal Shooliz
- Ages
- 18 Years - 75 Years
- Sexes
- All
-
Biobank for Potential or Known Genetic Diseases - Investigators
- Lizbeth Mellin-Sanchez, Pamela L Trapane
- Ages
- 0 Years - 100 Years
- Sexes
- All
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
The TwoPlus Study-Comparative Effectiveness of an Individualized Model of Hemodialysis vs. Conventional Hemodialysis - Investigator
- Alaa S Awad
- Ages
- 18 Years - N/A
- Sexes
- All
-
Access BNP Assay Clinical Subject Sample Collection Enrollment Study Protocol - Investigator
- Christine N Gage
- Ages
- 22 Years - 100 Years
- Sexes
- All
-
A Phase 1 Study of EG-70 as an Intravesical Administration to Patients with BCG -Unresponsive NMIBC - Investigator
- Mark G Bandyk
- Ages
- 18 Years - 101 Years
- Sexes
- All
-
SAGE-PsA Study Sex- And Gender-based analysis of the Effectiveness of advanced therapies in Psoriatic Arthritis - Ages
- 18 Years - 100 Years
- Sexes
- All
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All